Logo of The Journal of Bone & Joint Surgery (Br)
Joint Replacement Instrumentation Limited (JRI) Ad
Quick search:        
          Advanced Search
Guest Access | Sign In
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haddad, F. S.
Right arrow Articles by Duncan, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddad, F. S.
Right arrow Articles by Duncan, C. P.

The PROSTALAC functional spacer in two-stage revision for infected knee replacements

F. S. Haddad, BSc, MCh Orth, FRCS Orth, Clinical Research Fellow1; B. A. Masri, MD, FRCS C, Clinical Associate Professor1; D. Campbell, MD, Former Fellow1; R. W. McGraw, MD, FRCS C, Professor1; C. P. Beauchamp, MD, FRCS C, Assistant Professor2; and C. P. Duncan, MD, FRCS C, Professor and Chairman1

1 Department of Orthopaedics, University of British Columbia, Vancouver, British Columbia, Canada.
2 Mayo Clinic, Scottsdale, Arizona, USA.

Correspondence should be sent to Dr B. A. Masri at the Division of Reconstructive Orthopaedics, Third Floor, Laurel Pavilion, 910 West Tenth Avenue, Vancouver, British Columbia, Canada V5Z 4E3.

The PROSTALAC functional spacer is made of antibiotic-loaded acrylic cement but has a small metal-on-polythene articular surface. We have used it as an interim spacer in two-stage exchange arthroplasty for infected total knee replacement. PROSTALAC allows continuous rehabilitation between stages as it maintains good alignment and stability of the knee and a reasonable range of movement. It also helps to maintain the soft-tissue planes, which facilitates the second-stage procedure.

We reviewed 45 consecutive patients, treated over a period of nine years. The mean follow-up was for 48 months (20 to 112). At final review, there was no evidence of infection in 41 patients (91%); only one had a recurrent infection with the same organism. There was improvement in the Hospital for Special Surgery knee score between stages and at final review. The range of movement was maintained between stages. Complications were primarily related to the extensor mechanism and stability of the knee between stages. Both of these problems decreased with refinement of the design of the implant.

The rate of cure of the infection in our patients was similar to that using other methods. Movement of the knee does not appear to hinder control of infection.




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
D. A. Hoad-Reddick, C. R. Evans, P. Norman, and I. Stockley
Is there a role for extended antibiotic therapy in a two-stage revision of the infected knee arthroplasty?
J Bone Joint Surg Br, February 1, 2005; 87-B(2): 171 - 174.
[Abstract] [Full Text] [PDF]



(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General